Secretome vs. PRP Injections for Hair Density and Growth in Androgenetic Alopecia Patients

Trial statusRecruiting
Trial phasePhase 1, Phase 2
Trial typeInterventional
Biological sexAll
Age25-59
SponsorPT. Prodia Stem Cell Indonesia

About this trial

This study aims to compare the effectiveness of secretome injection and intradermal platelet-rich plasma (PRP) injection on hair density and the terminal-to-vellus hair ratio in patients with androgenetic alopecia at Prof. Dr. I.G.N.G. Ngoerah General Hospital.

Eligibility criteria

Qualifiers

Male patients with androgenetic alopecia, aged 25 to 59 years, with clinical presentation consistent with Hamilton-Norwood grades II to VI, seeking treatment at the Dermatology and Venereology Outpatient Clinic of Prof. Dr. I.G.N.G. Ngoerah General Hospital.

Female patients with androgenetic alopecia, aged 25 to 59 years, with clinical presentation consistent with Ludwig grades I to III, seeking treatment at the Dermatology and Venereology Outpatient Clinic of Prof. Dr. I.G.N.G. Ngoerah General Hospital.

Female patients who are not currently pregnant or breastfeeding.

Patients who have discontinued anti-androgen medication and minoxidil for at least 1 month prior to the procedure.

Disqualifiers

Participants who are unable to speak or understand Indonesian and/or are unwilling to provide written informed consent.

Patients presenting with types of hair loss other than androgenetic alopecia.

Patients currently undergoing therapy with 5-alpha reductase inhibitors.

Patients who have received intradermal corticosteroid injections to the scalp within at least 6 months prior to the study.

Trial design

Treatments tested in this trial

  • Secretome
  • Platelet-Rich Plasma (PRP) Injections

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators

PT. Prodia Stem Cell Indonesia

Lead sponsor

RS Prof. Dr. I.G.N.G Ngoerah

Collaborator